Revvity (NYSE:RVTY) CAO Sells 84 Shares of Company Stock

Revvity Inc. (NYSE:RVTY) CAO Anita Gonzales sold 84 shares of the stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $155.48, for a total value of $13,060.32. Following the transaction, the chief accounting officer directly owned 7,117 shares in the company, valued at $1,106,551.16. The trade was a 1.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Anita Gonzales also recently made the following trade(s):

• On Monday, July 20th, Anita Gonzales sold 85 shares of Revvity stock. The shares were sold at an average price of $109.48, for a total value of $9,305.80.

Revvity Stock Up 1.6%

Shares of RVTY stock traded up $2.40 on Friday, hitting $151.46. The stock had a trading volume of 1,235,180 shares, compared to its average volume of 1,499,707. Revvity Inc. has a one year low of $81.22 and a one year high of $158.28. The business has a 50 day moving average price of $127.45 and a 200 day moving average price of $108.40. The company has a market cap of $16.90 billion, a PE ratio of 72.13, a P/E/G ratio of 2.78 and a beta of 1.06. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.20. The company had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm’s quarterly revenue was down 1.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Research analysts anticipate that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s dividend payout ratio (DPR) is currently 13.33%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 30th. Evercore restated an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Finally, TD Cowen reissued a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Four research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $116.57.

Institutional Trading of Revvity

Hedge funds and other institutional investors have recently made changes to their positions in the business. EdgePoint Investment Group Inc. boosted its position in shares of Revvity by 3.1% in the 1st quarter. EdgePoint Investment Group Inc. now owns 8,800,863 shares of the company’s stock worth $771,044,000 after purchasing an additional 265,204 shares in the last quarter. Jupiter Topco LLC acquired a new position in Revvity during the 2nd quarter valued at about $961,017,000. Janus Henderson Group PLC increased its position in Revvity by 2.3% during the 1st quarter. Janus Henderson Group PLC now owns 8,348,127 shares of the company’s stock valued at $731,386,000 after buying an additional 186,956 shares in the last quarter. BlackRock Inc. purchased a new stake in Revvity in the second quarter valued at about $852,070,000. Finally, State Street Corp raised its stake in Revvity by 0.8% in the second quarter. State Street Corp now owns 4,342,739 shares of the company’s stock valued at $483,173,000 after buying an additional 32,426 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.